Hancock’s perilous position a problem for the NHS

The future of the UK NHS is changing according to the recent White Paper and Queen's Speech - we're moving towards collaboration not competition and a Secretary of State for Health with wider powers. But current incumbent Matt Hancock's reputation is damaged and his political capital on the wane. HBI heard at a Kings Fund digital event that this could prove a problem for the NHS.

Palamon pushes Bridgepoint off IDH/mydentist sale

Palamon Capital, the minority shareholder of dental group IDH/mydentist has bought majority control from Carlyle. Bridgepoint had earlier bought the group for £700m but Palamon has now exercised a right of first offer to push it out of the sale. 

The deals you can expect to see in the next two months

M&A slowed to a trickle during COVID but the next six weeks will see a flood of deals. HBI examines the deals that are about to happen, the companies looking to IPO, and reviews a handful of deals that remain resolutely on hold for the moment.

Bridgepoint’s IDH buy could signal pan-European ambitions

Bridgepoint has been confirmed as the buyer for the UK's largest dental group IDH/mydentist, which is to be sold on a 10x EBITDA multiple. The private equity firm already owns a Norwegian dental asset and others are coming to market in the next 12 months, so the deal could see the emergence of another pan-European dental group. But it is a poor outcome for current holders Carlyle and Palamon.

Interview: Raj Shah, Partner and Head of Healthcare, Nordic Capital

Few investors have been as active in healthcare services as Nordic Capital. Or as ambitious in building pan-European platforms in outpatient sectors such as dentistry, veterinary and ophthalmology. Raj Shah is also looking for new deals - Nordic has just raised a massive €6.1bn for its tenth fund of which 30-40% is destined for healthcare. 

2021: A boom year for health care M&A

The M&A market has roared out of Covid in the first quarter according to the HBI Panel Discussion. Are multiples likely to drop and what is investor appetite?

Mehilainen targets Estonia for international expansion

Finnish outpatient and occupational healthcare specialist Mehilainen has made two acquisitions in Estonia. The company says strong expansion into Estonia is a natural next step in Mehilainen’s internationalisation strategy.

Khemka’s big plans for Simplyhealth

Sneh Khemka has quit Aetna International where he was VP of Population Health & vHealth to become CEO of Simplyhealth, a £240m revenue, not-for-profit provider of cashplans for corporates and private individuals which in total covers 2.3m people in the UK. He tells us that his brief is to rethink how Simplyhealth can best provide access to health care services over the next 30-50 years.

Find Us